Gahan J. Pandina: Adjunctive Risperidone in the Treatment of Generalized Anxiety Disorder: A Double-Blind, Prospective, Placebo-Controlled, Randomized Trial

Name: Gahan J. Pandina: Adjunctive Risperidone in the Treatment of Generalized Anxiety Disorder: A Double-Blind, Prospective, Placebo-Controlled, Randomized Trial
SKU: pb-40-3-pandina
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

SKU: pb-40-3-pandina Categories: Psychopharmacology Bulletin, VOL 40 No. 3 Articles Tags: carla-m-canuso, gahan-j-pandina, generalized-anxiety-disorder, ibrahim-turkoz, mary-kujawa, md, mph, ms, phd, ramy-a-mahmoud, risperidone-adjunctive-treatment, selective-serotonin-receptor-inhibitors

Description

Gahan J. Pandina: Adjunctive Risperidone in the Treatment of Generalized Anxiety Disorder: A Double-Blind, Prospective, Placebo-Controlled, Randomized Trial

Description

Gahan J. Pandina, PhD Link

NEGATIVE AND FAILED CLINICAL TRIAL REPORTS

Adjunctive Risperidone in the Treatment of Generalized Anxiety Disorder: A Double-Blind, Prospective, Placebo-Controlled, Randomized Trial

Gahan J. Pandina, PhD, Carla M. Canuso, MD, Ibrahim Turkoz, MS, Mary Kujawa, MD, PhD, and Ramy A. Mahmoud, MD, MPH

New Goals in the Treatment of Depression: Moving Toward Recovery By Michael E. Thase, MD, and Philip T. Ninan, MD

P. Murali Doraiswamy, MD: Donepezil for Cognitive Decline Following Coronary Artery Bypass Surgery: A Pilot Randomized Controlled Trial

Eileen P. Ahearn, MD, PhD: Fear, Anxiety, and the Neuroimaging of PTSD

Aysegul Yolga Tahiroglu, MD: Polypharmacy and EPS in a Child; A Case Report

Gahan J. Pandina: Adjunctive Risperidone in the Treatment of Generalized Anxiety Disorder: A Double-Blind, Prospective, Placebo-Controlled, Randomized Trial

Description

Gahan J. Pandina, PhD Link

NEGATIVE AND FAILED CLINICAL TRIAL REPORTS

Adjunctive Risperidone in the Treatment of Generalized Anxiety Disorder: A Double-Blind, Prospective, Placebo-Controlled, Randomized Trial

Gahan J. Pandina, PhD, Carla M. Canuso, MD, Ibrahim Turkoz, MS, Mary Kujawa, MD, PhD, and Ramy A. Mahmoud, MD, MPH

Related products

New Goals in the Treatment of Depression: Moving Toward Recovery By Michael E. Thase, MD, and Philip T. Ninan, MD

P. Murali Doraiswamy, MD: Donepezil for Cognitive Decline Following Coronary Artery Bypass Surgery: A Pilot Randomized Controlled Trial

Eileen P. Ahearn, MD, PhD: Fear, Anxiety, and the Neuroimaging of PTSD

Aysegul Yolga Tahiroglu, MD: Polypharmacy and EPS in a Child; A Case Report